Evidence map›Paper›PMID 39639258›Full record

ArticleBMC cancer2024

A multi-view prognostic model for diffuse large B-cell lymphoma based on kernel canonical correlation analysis and support vector machine.

Yanhong Luo, Yongao Li, Zhenhuan Yang, Yanbo Zhang, Hongmei Yu, Zhiqiang Zhao, Kai Yu, Yujiao Guo, Xueman Wang, Na Yang and 3 more

Abstract read
In one paragraph

Article in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yanhong LuoDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, China. sxmulyh@163.com.
Yongao LiDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, China.
Zhenhuan YangDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, China.
Yanbo ZhangDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, China.
Hongmei YuDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, China.
Zhiqiang ZhaoDepartment of Hematology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, 030013, China.
Kai YuDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, China.
Yujiao GuoDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, China.
Xueman WangDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, China.
Na YangDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, China.
Yan ZhangDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, China.
Tingting ZhengDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, 030001, China.
Jie ZhouDepartment of Nuclear Medicine, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, 030013, China. zhoujiezjzhoujie@163.com.

Funding

Applied Basic Research Project of Shanxi Province, China 202103021224245National Natural Science Foundation of China 81502897Shanxi Province Graduate Education Innovation Program 2024JG088Teaching Reform and Innovation Program for Higher Education Institutions in Shanxi Province J20240531
6 · The paper itself

Abstract

BACKGROUND AND

objectivePositron emission tomography/computed tomography (PET/CT) is recommended as the standard imaging modality for diffuse large B-cell lymphoma (DLBCL) staging. However, many studies have neglected the role of patients' prognostic factors with respect to imaging PET/CT of quantitative features. In this paper, a multi-view learning (MVL) model is established to make full use of both clinical and imaging data to predict the prognosis of DLBCL patients and thereby assist doctors in decision-making.

methodsFeature engineering, including feature extraction, feature screening by recursive feature elimination, and dimensionality reduction by principal component analysis, are successively performed on the clinical data and imaging data of the research subjects to obtain the study data. After dividing the data into training and test sets, an instance weighting method is applied to the training data. Subsequently, kernel mapping is performed on the imaging features and clinical features separately, and this kernel mapping is processed in the new kernel feature space using kernel canonical correlation analysis (KCCA). Lastly, model training is performed on the obtained common kernel subspace using a support vector machine (SVM). The final overall model, named SVM-2view-KCCA (SVM-2 K), was compared with three other multi-view models (Ensemble-SVM, Multi-view maximum entropy discrimination, and canonical correlation analysis). The performance of the model was evaluated on the test data with respect to several dichotomous metrics: accuracy, sensitivity, F1 score, the area under the curve (AUC), and G-mean.

resultsThe SVM model improved AUC by 10.5%, sensitivity by 11.9%, accuracy by 9.8%, F1 score by 9.2%, and G-mean by 7.8% for the DLBCL test data after feature engineering based on dimensionality reduction and instance weighting. In the performance comparison of single-view learning models, the SVM-based integration of clinical and imaging features achieved the best overall performance (AUC = 86.3%, accuracy = 91.6%, sensitivity = 83.2%, F1 = 85.7%, and G-mean = 86.1%). In the comparison of MVL models, SVM-2 K achieved the best overall performance (AUC = 92.1%, accuracy = 96.9%, sensitivity = 90.9%, F1 = 92.8%, and G-mean = 91.4%), and the performance of each MVL model was better than that of the best single-view learning model.

conclusionsMVL models outperformed single-view learning models. Of the MVL models, the proposed SVM-2 K achieved the best overall performance and could accurately predict patient prognosis.

Indexed as

Lymphoma, Large B-Cell, DiffusePositron Emission Tomography Computed TomographySupport Vector MachineAdultAgedFemaleHumansMaleMiddle AgedPrognosisROC CurveDiffuse large B-cell lymphomaDisease prognosisKernel canonical correlation analysisMulti-view learningSupport vector machine

Identifiers

PMID39639258
PMCPMC11619205

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.